Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.227788
-0.0258 (-10.18%)
Oct 8, 2026, 2:00 PM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.27 million as of October 8, 2026. It is the 48,834th most valuable company in the world and the 6,637th biggest in the United States. Its market cap has decreased by 44.39% in one year.
Market Cap
1.27M
Enterprise Value
447.56K
1-Year Change
-44.39%
Global Rank
Country Rank
#6,637 United States
Category
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $1.27M, a decrease of -99.15%. That is a compound annual growth rate of -57.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.46M | -75.66% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.19M |
| Lakewood-Amedex Biotherapeutics | 2.03M |
| Alaunos Therapeutics | 2.02M |
| Artelo Biosciences | 1.92M |
| Virax Biolabs Group | 1.91M |
| Curis | 1.65M |
| Bone Biologics | 1.34M |
| Tessera Defense and Homeland Security | 1.12M |